Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH)
Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
1. To assess the metabolic factors in lean and obese patients with NASH.
2. To compare the efficacy of pentoxifylline versus pioglitazone on the metabolic profile
and liver histology of NASH patients.